Risk factors for bone metastasis from renal cell cancer

Objective: The prognosis for renal cell carcinoma (RCC) is related to a high rate of metastasis, including 30% of bone metastasis. In this study, we investigate the correlation between diverse clinical factors and bone metastases secondary from renal cell cancer (RCC), and to identify potential risk...

Full description

Bibliographic Details
Main Authors: Xuan-Yin Chen, Min Lan, Yang Zhou, Wen-Zhao Chen, Dong Hu, Jia-Ming Liu, Shan-Hu Huang, Zhi-Li Liu, Zhi-Hong Zhang
Format: Article
Language:English
Published: Elsevier 2017-11-01
Series:Journal of Bone Oncology
Online Access:http://www.sciencedirect.com/science/article/pii/S2212137417300957
id doaj-217eaf2deaad4b34801ad953fca8a356
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Xuan-Yin Chen
Min Lan
Yang Zhou
Wen-Zhao Chen
Dong Hu
Jia-Ming Liu
Shan-Hu Huang
Zhi-Li Liu
Zhi-Hong Zhang
spellingShingle Xuan-Yin Chen
Min Lan
Yang Zhou
Wen-Zhao Chen
Dong Hu
Jia-Ming Liu
Shan-Hu Huang
Zhi-Li Liu
Zhi-Hong Zhang
Risk factors for bone metastasis from renal cell cancer
Journal of Bone Oncology
author_facet Xuan-Yin Chen
Min Lan
Yang Zhou
Wen-Zhao Chen
Dong Hu
Jia-Ming Liu
Shan-Hu Huang
Zhi-Li Liu
Zhi-Hong Zhang
author_sort Xuan-Yin Chen
title Risk factors for bone metastasis from renal cell cancer
title_short Risk factors for bone metastasis from renal cell cancer
title_full Risk factors for bone metastasis from renal cell cancer
title_fullStr Risk factors for bone metastasis from renal cell cancer
title_full_unstemmed Risk factors for bone metastasis from renal cell cancer
title_sort risk factors for bone metastasis from renal cell cancer
publisher Elsevier
series Journal of Bone Oncology
issn 2212-1374
publishDate 2017-11-01
description Objective: The prognosis for renal cell carcinoma (RCC) is related to a high rate of metastasis, including 30% of bone metastasis. In this study, we investigate the correlation between diverse clinical factors and bone metastases secondary from renal cell cancer (RCC), and to identify potential risk factors for bone metastasis in newly diagnosed patients and those who have already received treatment. Methods: The clinical data of 372 patients with RCC were reviewed from January 2000 to August 2016. The correlations between age, gender, histopathologic types, alkaline phosphotase (ALP), CEA, AFP, CA-125, CA-153, CA-199, calcium, hemoglobin (HB) and bone metastases were analyzed. And the risk factors for bone metastases in RCC were identified by multivariate logistic regression analysis. The cutoff value, sensitivity and specificity of the independent correlation factors were calculated by receiver operating characteristic (ROC) curve. Results: The bone is the second to the lung as a distant metastasis target site in patients with RCC. Thirty eight individuals were identified with bone metastases. Of these patients, significantly higher levels of ALP, calcium, HB were found than those without bone metastasis (P < 0.05, respectively). No significant differences were detected in CEA, AFP, CA-125, CA-153, CA-199, age, gender and histopathologic types between patients with and without bone metastases (P > 0.05, respectively). Multivariate logistic regression analysis indicated that ALP, calcium and HB were independent risk factors correlated with bone metastasis (P < 0.05, respectively). ROC curves demonstrated these factors had comparable accuracy at predicting bone metastasis (AUC were 0.749, 0.633 and 0.665, respectively). The cutoff values of ALP, calcium and HB were 105.5 U/L, 2.615 mmol/L and 111.5 g/L, respectively. The sensitivities of them were 57.9%, 36.8% and 71.1% for predicting bone metastasis, with specificities of 83.5%, 95.2% and 65.3%, respectively. Conclusion: Based on our study, the concentrations of ALP, calcium and HB were potentially risk factors for bone metastasis in patients with RCC. For newly diagnosed patients, if the values of ALP>105.5 U/L, calcium>2.615 mmol/L and HB<111.5 g/L were detected, intensive monitoring and bone scanning are warranted for them. Keywords: Bone metastases, Renal cell cancer, Risk factors
url http://www.sciencedirect.com/science/article/pii/S2212137417300957
work_keys_str_mv AT xuanyinchen riskfactorsforbonemetastasisfromrenalcellcancer
AT minlan riskfactorsforbonemetastasisfromrenalcellcancer
AT yangzhou riskfactorsforbonemetastasisfromrenalcellcancer
AT wenzhaochen riskfactorsforbonemetastasisfromrenalcellcancer
AT donghu riskfactorsforbonemetastasisfromrenalcellcancer
AT jiamingliu riskfactorsforbonemetastasisfromrenalcellcancer
AT shanhuhuang riskfactorsforbonemetastasisfromrenalcellcancer
AT zhililiu riskfactorsforbonemetastasisfromrenalcellcancer
AT zhihongzhang riskfactorsforbonemetastasisfromrenalcellcancer
_version_ 1725277919294521344
spelling doaj-217eaf2deaad4b34801ad953fca8a3562020-11-25T00:43:30ZengElsevierJournal of Bone Oncology2212-13742017-11-0192933Risk factors for bone metastasis from renal cell cancerXuan-Yin Chen0Min Lan1Yang Zhou2Wen-Zhao Chen3Dong Hu4Jia-Ming Liu5Shan-Hu Huang6Zhi-Li Liu7Zhi-Hong Zhang8Department of Orthopaedic Surgery, the First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Donghu District, Nanchang, Jiangxi Province 330006, PR ChinaDepartment of Orthopaedic Surgery, the First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Donghu District, Nanchang, Jiangxi Province 330006, PR ChinaDepartment of Orthopaedic Surgery, the First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Donghu District, Nanchang, Jiangxi Province 330006, PR ChinaDepartment of Orthopaedic Surgery, the First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Donghu District, Nanchang, Jiangxi Province 330006, PR ChinaDepartment of Orthopaedic Surgery, the First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Donghu District, Nanchang, Jiangxi Province 330006, PR ChinaDepartment of Orthopaedic Surgery, the First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Donghu District, Nanchang, Jiangxi Province 330006, PR ChinaDepartment of Orthopaedic Surgery, the First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Donghu District, Nanchang, Jiangxi Province 330006, PR ChinaCorresponding authors.; Department of Orthopaedic Surgery, the First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Donghu District, Nanchang, Jiangxi Province 330006, PR ChinaCorresponding authors.; Department of Orthopaedic Surgery, the First Affiliated Hospital of Nanchang University, No. 17 Yongwaizheng Street, Donghu District, Nanchang, Jiangxi Province 330006, PR ChinaObjective: The prognosis for renal cell carcinoma (RCC) is related to a high rate of metastasis, including 30% of bone metastasis. In this study, we investigate the correlation between diverse clinical factors and bone metastases secondary from renal cell cancer (RCC), and to identify potential risk factors for bone metastasis in newly diagnosed patients and those who have already received treatment. Methods: The clinical data of 372 patients with RCC were reviewed from January 2000 to August 2016. The correlations between age, gender, histopathologic types, alkaline phosphotase (ALP), CEA, AFP, CA-125, CA-153, CA-199, calcium, hemoglobin (HB) and bone metastases were analyzed. And the risk factors for bone metastases in RCC were identified by multivariate logistic regression analysis. The cutoff value, sensitivity and specificity of the independent correlation factors were calculated by receiver operating characteristic (ROC) curve. Results: The bone is the second to the lung as a distant metastasis target site in patients with RCC. Thirty eight individuals were identified with bone metastases. Of these patients, significantly higher levels of ALP, calcium, HB were found than those without bone metastasis (P < 0.05, respectively). No significant differences were detected in CEA, AFP, CA-125, CA-153, CA-199, age, gender and histopathologic types between patients with and without bone metastases (P > 0.05, respectively). Multivariate logistic regression analysis indicated that ALP, calcium and HB were independent risk factors correlated with bone metastasis (P < 0.05, respectively). ROC curves demonstrated these factors had comparable accuracy at predicting bone metastasis (AUC were 0.749, 0.633 and 0.665, respectively). The cutoff values of ALP, calcium and HB were 105.5 U/L, 2.615 mmol/L and 111.5 g/L, respectively. The sensitivities of them were 57.9%, 36.8% and 71.1% for predicting bone metastasis, with specificities of 83.5%, 95.2% and 65.3%, respectively. Conclusion: Based on our study, the concentrations of ALP, calcium and HB were potentially risk factors for bone metastasis in patients with RCC. For newly diagnosed patients, if the values of ALP>105.5 U/L, calcium>2.615 mmol/L and HB<111.5 g/L were detected, intensive monitoring and bone scanning are warranted for them. Keywords: Bone metastases, Renal cell cancer, Risk factorshttp://www.sciencedirect.com/science/article/pii/S2212137417300957